tiger.PHARMA supports manufacturers with pharmaceutical wholesale listings in Germany: product and PZN data, distributor requirements, commercial terms, initial stocking, ordering and launch acceptance.
Wholesale listing is a coordinated commercial and operational process. Correct IFA data makes the product identifiable; acceptance by a wholesaler, initial stock and reliable order fulfilment require additional decisions and evidence.
tiger.PHARMA Expertise
Topics we master
Prepare the wholesale listing brief
Define the product, pack sizes, PZN, supplier, regulatory status and target wholesalers before approaching the distribution channel.
Product and supplier master data
Target channel and customer segments
Launch date and initial demand assumptions
Required documents and decision owners
Align IFA product data and PZN
Published data must agree with the product, trade and pack information used by the manufacturer, wholesaler and pharmacy systems. Changes are reviewed against the relevant IFA process.
PZN and pack identification
Product status and publication dates
Price, trade and order data
Data checks and change responsibility
Coordinate distributor acceptance and terms
Each wholesaler's requirements and commercial decision are handled explicitly. A submission is tracked through open questions, agreements and confirmed acceptance rather than treated as a guaranteed listing.
Distributor-specific submission requirements
Commercial and delivery terms
Returns and service responsibilities
Acceptance status and unresolved items
Plan initial stock and replenishment
Initial stocking connects the launch forecast with warehouse capacity, shelf life, lead times and replenishment. Availability is checked against the agreed customer and ordering model.
Initial quantities and stock ownership
Forecast and replenishment triggers
Shelf life and temperature conditions
Service levels and shortage escalation
Test pharmacy orderability
Validate the actual ordering route and the response seen by the pharmacy. Confirm the product, price, available quantity, delivery and invoice in the relevant systems.
PZN enquiry and test order
Price and quantity response
ERP, WMS and MSV3 handover where applicable
Delivery, invoice and exception handling
Acceptance matrix: separate data status, listing and availability
PZN or IFA publication, a commercial wholesale listing, branch-level inventory and a successfully confirmed order are distinct acceptance stages. For each target wholesaler and branch, tiger.PHARMA therefore records the evidence actually available and the gap remaining before stable replenishment.
IFA/PZN dataset published and visible in target systems
Article listed centrally or by branch
Inventory, block and backorder status checked
Test order with order confirmation and delivery status
First delivery, replenishment and returns route accepted
FAQ
Frequently asked questions
What is a pharmaceutical wholesale listing?
It is the acceptance and setup of a product in a wholesaler's commercial and operational systems. The assignment can cover data, terms, stocking and orderability, with the final acceptance decision remaining with the wholesaler.
Does IFA publication automatically create a wholesale listing?
No. IFA publication, distributor acceptance and available stock are separate states. Each needs to be confirmed for the planned launch.
Can tiger.PHARMA guarantee listing with every wholesaler?
No. Each wholesaler assesses its own requirements and commercial model. We structure the submission, coordinate questions and document the outcome.
tiger.PHARMA Leistungen
Related specialist services
From planning to ongoing operations: choose the right service module for your implementation.